Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, 02 avr. 2026 (GLOBE NEWSWIRE) -- Crohn et Colite Canada et AbbVie sont heureux d'annoncer l'ouverture des candidatures pour le Programme de bourses d'études MII d’AbbVie 2026. Cette année...
-
Crohn’s and Colitis Canada and AbbVie open applications for the 2026 AbbVie IBD Scholarship, marking 15 years of supporting students living with IBD.
-
West Red Lake Gold Mines announces the appointment of Jaclyn Ruptash as Vice President, Communications, further strengthening its leadership team/
-
LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
-
Financial Close Software Market grows as enterprises adopt cloud-based automation to streamline financial reporting, compliance, month-end close processes.
-
Brand New Online Casino USA for Real-Money: The 2026 SweepsPulse List outlines new casino launches, bonuses, and real cash play features.
-
NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (“Figure”) (Nasdaq: FIGR) today announced a strategic partnership with Agora Data, a leading AI-powered auto fintech platform,...
-
Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "Negotiation Skills for Contracts and Commercial Managers Training Course (Mar 16, 2026)" training has been added to ResearchAndMarkets.com's offering....
-
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
REDWOOD CITY, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to transforming...
-
Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli...